argenx stock falls 1.79 percent as Goldman raises its target

Published on 10/04/2026 at 10:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

argenx stock posted USD 1.54 billion in Q2 revenue on July 21, 2026, beating the USD 1.45 billion consensus. Goldman Sachs lifted its target to EUR 982.

Architekturaufnahme eines modernen Biotechnologie-Campus in Belgien, Glas-Stahl-Gebäude mit Dachgärten, Radfahrer auf baumgesäumter Allee, nordeeuropäischer Himmel — Argenx NL0010832176 moderner belgischer Biotech-Campus mit Glasfassaden und Radfahrern unter bewölktem Herbsthimmel, Illustration mit AI erstellt.

argenx (ISIN NL0010832176) was last at USD 919.21 on Nasdaq on October 2, 2026 at 4:00 p.m. ET, down 1.79 percent from the previous close of USD 936.00. The move came as analysts continued to frame the next earnings report around the commercial momentum of Vyvgart.

Q2 revenue beats consensus

According to MarketBeat, argenx reported USD 1.54 billion in revenue and adjusted earnings per share of USD 7.32 for Q2 2026, reported on July 21, 2026. Revenue exceeded the USD 1.45 billion analyst estimate, while earnings per share surpassed the USD 5.86 consensus by USD 1.46.

The Q2 figures give the stock a concrete operating benchmark after the October 2 market move. Revenue was the stronger signal because the company exceeded expectations on both sales and earnings in the same quarter.

Goldman raises its target

FinanzNachrichten.de reported on September 25, 2026 that Goldman Sachs raised its 12-month price target from EUR 973 to EUR 982 and kept a Buy rating. Analyst Rajan Sharma cited potential for Vyvgart expectations to surprise by a low to mid single-digit percentage before the October 22 quarterly report.

The analyst view adds a forward checkpoint to the Q2 comparison. It also leaves the October 22 report as the next major date for testing whether sales growth can support the valuation after the stock traded below its 52-week high.

Stock remains below yearly high

argenx stock had a 52-week range of USD 661.85 to USD 1,072.75 on October 2, 2026, with volume of 333,869 shares. Its market capitalization was USD 57.2 billion on the same date, placing the USD 919.21 price below the upper end of its annual range.

The company lists Nasdaq and Euronext as trading venues on its investor site. For investors, the central question is whether the Q2 revenue beat and Goldman Sachs target increase can be reinforced by the October 22 results.

October results set the next test

argenx stock was last at USD 919.21 on Nasdaq on October 2, 2026 at 4:00 p.m. ET. The next quantified checkpoints are the USD 1.54 billion Q2 revenue figure, the USD 7.32 adjusted earnings per share result and the October 22 reporting date.